Your browser doesn't support javascript.
loading
Quantitative and qualitative mutational impact of ionizing radiation on normal cells.
Youk, Jeonghwan; Kwon, Hyun Woo; Lim, Joonoh; Kim, Eunji; Kim, Taewoo; Kim, Ryul; Park, Seongyeol; Yi, Kijong; Nam, Chang Hyun; Jeon, Sara; An, Yohan; Choi, Jinwook; Na, Hyelin; Lee, Eon-Seok; Cho, Youngwon; Min, Dong-Wook; Kim, HyoJin; Kang, Yeong-Rok; Choi, Si Ho; Bae, Min Ji; Lee, Chang Geun; Kim, Joon-Goon; Kim, Young Seo; Yu, Tosol; Lee, Won-Chul; Shin, Jong-Yeon; Lee, Dong Soo; Kim, Tae-You; Ku, Taeyun; Kim, Su Yeon; Lee, Joo-Hyeon; Koo, Bon-Kyoung; Lee, Hyunsook; Yi, On Vox; Han, Eon Chul; Chang, Ji Hyun; Kim, Kyung Su; Son, Tae Gen; Ju, Young Seok.
Afiliación
  • Youk J; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
  • Kwon HW; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea; Department of Nuclear Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Lim J; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea; Genome Insight, Inc., San Diego, CA 92121, USA.
  • Kim E; Department of Radiation Oncology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, 20, Boramae-ro 5 Gil, Dongjak-gu, Seoul 07061, Republic of Korea; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Kim T; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
  • Kim R; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea; Genome Insight, Inc., San Diego, CA 92121, USA.
  • Park S; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea; Genome Insight, Inc., San Diego, CA 92121, USA.
  • Yi K; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea; Genome Insight, Inc., San Diego, CA 92121, USA.
  • Nam CH; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
  • Jeon S; Department of Biological Sciences & IMBG, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea.
  • An Y; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
  • Choi J; Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, CB2 0AW Cambridge, UK; Department of Physiology, Development and Neuroscience, University of Cambridge, CB2 3EL Cambridge, UK.
  • Na H; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Dr. Bohr-Gasse 3, 1030 Vienna, Austria.
  • Lee ES; Research Center, Dongnam Institute of Radiological and Medical Science, Busan, Republic of Korea.
  • Cho Y; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
  • Min DW; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
  • Kim H; Research Center, Dongnam Institute of Radiological and Medical Science, Busan, Republic of Korea.
  • Kang YR; Research Center, Dongnam Institute of Radiological and Medical Science, Busan, Republic of Korea.
  • Choi SH; Research Center, Dongnam Institute of Radiological and Medical Science, Busan, Republic of Korea.
  • Bae MJ; Research Center, Dongnam Institute of Radiological and Medical Science, Busan, Republic of Korea.
  • Lee CG; Research Center, Dongnam Institute of Radiological and Medical Science, Busan, Republic of Korea.
  • Kim JG; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea; KI for Health Science and Technology, KAIST, Daejeon 34141, Republic of Korea.
  • Kim YS; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea; KI for Health Science and Technology, KAIST, Daejeon 34141, Republic of Korea.
  • Yu T; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Department of Radiation Oncology, Dongnam Institute of Radiological and Medical Science, Busan 46033, Republic of Korea.
  • Lee WC; Genome Insight, Inc., San Diego, CA 92121, USA.
  • Shin JY; Genome Insight, Inc., San Diego, CA 92121, USA.
  • Lee DS; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Kim TY; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea; Department of Internal Medicine, Seoul Na
  • Ku T; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea; KI for Health Science and Technology, KAIST, Daejeon 34141, Republic of Korea.
  • Kim SY; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
  • Lee JH; Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, CB2 0AW Cambridge, UK; Department of Physiology, Development and Neuroscience, University of Cambridge, CB2 3EL Cambridge, UK.
  • Koo BK; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Dr. Bohr-Gasse 3, 1030 Vienna, Austria.
  • Lee H; Department of Biological Sciences & IMBG, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea.
  • Yi OV; Department of Breast Surgery, Dongnam Institute of Radiological and Medical Science, Busan, Republic of Korea.
  • Han EC; Department of Surgery, Dongnam Institute of Radiological and Medical Science, Busan, Republic of Korea.
  • Chang JH; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: jh.chang@snu.ac.kr.
  • Kim KS; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: kskim.cirt@snu.ac.kr.
  • Son TG; Research Center, Dongnam Institute of Radiological and Medical Science, Busan, Republic of Korea. Electronic address: tgson@dirams.re.kr.
  • Ju YS; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea; Genome Insight, Inc., San Diego, CA 92121, USA. Electronic address: ysju@kaist.ac.kr.
Cell Genom ; 4(2): 100499, 2024 Feb 14.
Article en En | MEDLINE | ID: mdl-38359788
ABSTRACT
The comprehensive genomic impact of ionizing radiation (IR), a carcinogen, on healthy somatic cells remains unclear. Using large-scale whole-genome sequencing (WGS) of clones expanded from irradiated murine and human single cells, we revealed that IR induces a characteristic spectrum of short insertions or deletions (indels) and structural variations (SVs), including balanced inversions, translocations, composite SVs (deletion-insertion, deletion-inversion, and deletion-translocation composites), and complex genomic rearrangements (CGRs), including chromoplexy, chromothripsis, and SV by breakage-fusion-bridge cycles. Our findings suggest that 1 Gy IR exposure causes an average of 2.33 mutational events per Gb genome, comprising 2.15 indels, 0.17 SVs, and 0.01 CGRs, despite a high level of inter-cellular stochasticity. The mutational burden was dependent on total irradiation dose, regardless of dose rate or cell type. The findings were further validated in IR-induced secondary cancers and single cells without clonalization. Overall, our study highlights a comprehensive and clear picture of IR effects on normal mammalian genomes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Translocación Genética / Reordenamiento Génico Tipo de estudio: Qualitative_research Límite: Animals / Humans Idioma: En Revista: Cell Genom Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Translocación Genética / Reordenamiento Génico Tipo de estudio: Qualitative_research Límite: Animals / Humans Idioma: En Revista: Cell Genom Año: 2024 Tipo del documento: Article